Correlation Between Definitive Healthcare and Neuropace

Can any of the company-specific risk be diversified away by investing in both Definitive Healthcare and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Definitive Healthcare and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Definitive Healthcare Corp and Neuropace, you can compare the effects of market volatilities on Definitive Healthcare and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Definitive Healthcare with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Definitive Healthcare and Neuropace.

Diversification Opportunities for Definitive Healthcare and Neuropace

0.62

Correlation Coefficient

Definitive Healthcare  Neuropace

Poor diversification

The 3 months correlation between Definitive and Neuropace is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Definitive Healthcare Corp and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Definitive Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Definitive Healthcare Corp are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Definitive Healthcare i.e., Definitive Healthcare and Neuropace go up and down completely randomly.

Pair Corralation between Definitive Healthcare and Neuropace

Allowing for the 90-day total investment horizon Definitive Healthcare Corp is expected to under-perform the Neuropace. In addition to that, Definitive Healthcare is 1.51 times more volatile than Neuropace. It trades about -0.11 of its total potential returns per unit of risk. Neuropace is currently generating about 0.02 per unit of volatility. If you would invest  1,242  in Neuropace on January 7, 2025 and sell it today you would lose (12.00) from holding Neuropace or give up 0.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Definitive Healthcare Corp  vs.  Neuropace

Definitive Healthcare

Risk-Adjusted Performance

Very Weak

Over the last 90 days Definitive Healthcare Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical indicators remain fairly strong which may send shares a bit higher in May 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Neuropace

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Neuropace is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Definitive Healthcare and Neuropace

The main advantage of trading using opposite Definitive Healthcare and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Definitive Healthcare position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind Definitive Healthcare Corp and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.